Cargando…
Genomic alterations of oligodendrogliomas at distant recurrence
BACKGROUND: Oligodendroglioma is known for its relatively better prognosis and responsiveness to radiotherapy and chemotherapy. However, little is known about the evolution of genetic changes as oligodendroglioma progresses. METHODS: In this study, we evaluated gene evolution invivo during tumor pro...
Autores principales: | Liu, Guanzheng, Bu, Chaojie, Guo, Guangzhong, Zhang, Zhiyue, Sheng, Zhiyuan, Deng, Kaiyuan, Wu, Shuang, Xu, Sensen, Bu, Yage, Gao, Yushuai, Wang, Meiyun, Liu, Gang, Kong, Lingfei, Li, Tianxiao, Li, Ming, Bu, Xingyao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10501240/ https://www.ncbi.nlm.nih.gov/pubmed/37533228 http://dx.doi.org/10.1002/cam4.6327 |
Ejemplares similares
-
Molecular and clonal evolution in vivo reveal a common pathway of distant relapse gliomas
por: Liu, Guanzheng, et al.
Publicado: (2023) -
Real‐time longitudinal analysis of human gliomas reveals in vivo genome evolution and therapeutic impact under standardized treatment
por: Xu, Sensen, et al.
Publicado: (2022) -
Tumor DNA From Tumor In Situ Fluid Reveals Mutation Landscape of Minimal Residual Disease After Glioma Surgery and Risk of Early Recurrence
por: Yu, Jinliang, et al.
Publicado: (2021) -
Integrating real‐time in vivo tumour genomes for longitudinal analysis and management of glioma recurrence
por: Sheng, Zhiyuan, et al.
Publicado: (2021) -
Tracking tumor evolution during the first-line treatment in brain glioma via serial profiling of cell-free tumor DNA from tumor in situ fluid
por: Sheng, Zhiyuan, et al.
Publicado: (2023)